Buy Prevail Therapeutics Inc Stock | PRVL Stock Price & Latest News | Public.com
PRVL

Prevail Therapeutics Inc

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Prevail Therapeutics Inc (PRVL) stock trends here

    About PRVL

    Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease and other neurodegenerative diseases. Prevail was launched in 2017 by The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO, and Orb...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.24
    -0.48
    -0.72
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.68

    Actual EPS
    Q2 2021

    Stats

    Market Cap$787,7M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$23.35
    1 Year Low$9.02
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app